Shanghai Pharmaceutical Big Health Yunshang, formed in March with $100m of its parent company's cash, has raised another $174m in a round backed by JD.com and IDG Capital.
China-based online-to-offline health technology startup Shanghai Pharmaceutical Big Health Yunshang has raised RMB 1.11bn ($174m) in a round led by its parent company, Shanghai Pharmaceutical, China Money Network reported yesterday.
The publicly-listed pharmaceutical firm was joined in the round by e-commerce company JD.com and IDG Capital Partners, the Chinese venture capital affiliate of US-based media and data firm International Data Group.
Shanghai Pharmaceuticals invested $141m in stock and will retain a 75% share of Yunshang. JD is providing $23m of…
